rs150861311
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005101.4(ISG15):c.142C>T(p.His48Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000242 in 1,613,102 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005101.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ISG15 | NM_005101.4 | c.142C>T | p.His48Tyr | missense_variant | 2/2 | ENST00000649529.1 | NP_005092.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ISG15 | ENST00000649529.1 | c.142C>T | p.His48Tyr | missense_variant | 2/2 | NM_005101.4 | ENSP00000496832 | P1 | ||
ISG15 | ENST00000624697.4 | c.118C>T | p.His40Tyr | missense_variant | 3/3 | 3 | ENSP00000485643 | |||
ISG15 | ENST00000624652.1 | c.118C>T | p.His40Tyr | missense_variant | 3/3 | 3 | ENSP00000485313 |
Frequencies
GnomAD3 genomes AF: 0.000506 AC: 77AN: 152264Hom.: 1 Cov.: 35
GnomAD3 exomes AF: 0.000104 AC: 26AN: 250356Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135668
GnomAD4 exome AF: 0.000214 AC: 313AN: 1460838Hom.: 0 Cov.: 31 AF XY: 0.000205 AC XY: 149AN XY: 726662
GnomAD4 genome AF: 0.000506 AC: 77AN: 152264Hom.: 1 Cov.: 35 AF XY: 0.000497 AC XY: 37AN XY: 74386
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2023 | The c.142C>T (p.H48Y) alteration is located in exon 2 (coding exon 2) of the ISG15 gene. This alteration results from a C to T substitution at nucleotide position 142, causing the histidine (H) at amino acid position 48 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 25, 2021 | - - |
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2022 | This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 48 of the ISG15 protein (p.His48Tyr). This variant is present in population databases (rs150861311, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ISG15-related conditions. ClinVar contains an entry for this variant (Variation ID: 542074). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The tyrosine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at